Literature DB >> 21617852

Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.

Masanori Ii1, Hiroyuki Yamamoto, Hiroaki Taniguchi, Yasushi Adachi, Mayumi Nakazawa, Hirokazu Ohashi, Tokuma Tanuma, Yasutaka Sukawa, Hiromu Suzuki, Shigeru Sasaki, Kohzoh Imai, Yasuhisa Shinomura.   

Abstract

Laminin-332 (LM-332, formerly termed laminin-5) is a heterotrimeric glycoprotein that regulates cell adhesion and migration. Molecular alterations of LM-332 are involved in cancer progression. The aim of this study was to clarify alterations of LM-332 in gastric carcinoma. The expression of LM-332 subunits in 10 gastric carcinoma cell lines was investigated by RT-PCR, Western blotting, and immuno-cytochemical/immunofluorescent analyses. The promoter methylation status of LM-332-encoding genes (LAMA3, LAMB3 and LAMC2) was analyzed by methylation-specific PCR (MSP). The relationship between cell migration and LM-332 expression was assessed by the scratch assay. The expression of LM-332 was analyzed immunohistochemically in 90 gastric cancer tissues. Co-expression of laminin β3 and γ2 chains was often observed in gastric carcinoma cell lines at mRNA and protein levels. In contrast, there was no expression of laminin α3 at either the mRNA or protein levels. Extra-cellular secretion of laminin β3 and γ2 chains was found in 2 of the 10 cell lines. The LAMA3 gene was transcriptionally silenced by methylation of the promoter CpG islands in all of the cell lines, while the LAMB3 and LAMC2 genes were silenced in several cell lines. Treatment with a demethylating agent, 5-aza-2'-deoxycytidine (5-aza-dC), restored expression of the LM-332-encoding genes. Methylation frequency of LAMA3 was higher than those of the LAMB2 and LAMC2 genes in gastric cancer tissues. Migration distances were significantly correlated with cytoplasmic laminin γ2 chain expression. Immunohistochemistry showed frequent co-expression of laminin β3 and γ2 chains in gastric carcinoma cells, which was significantly correlated with depth of invasion and advanced tumor stage. The results suggest that the laminin β3 and γ2 chains accumulate intracellularly and play a role in gastric cancer progression, while epigenetic silencing of the laminin α3 chain may lead to inability to synthesize the basement membrane and may affect cancer cell invasion. Cancer cell motility appears to be associated with the cyto-plasmic laminin γ2 chain in vitro.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21617852     DOI: 10.3892/ijo.2011.1048

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

Review 1.  Epigenetic regulation and targeting of ECM for cancer therapy.

Authors:  Romi Gupta
Journal:  Am J Physiol Cell Physiol       Date:  2022-03-02       Impact factor: 4.249

2.  LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer.

Authors:  Li-Yuan Feng; Yong-Zhi Huang; Wei Zhang; Li Li
Journal:  J Ovarian Res       Date:  2021-05-15       Impact factor: 4.234

3.  Gene expression analysis in asthma using a targeted multiplex array.

Authors:  Christopher D Pascoe; Ma'en Obeidat; Bryna A Arsenault; Yunlong Nie; Stephanie Warner; Dorota Stefanowicz; Samuel J Wadsworth; Jeremy A Hirota; S Jasemine Yang; Delbert R Dorscheid; Chris Carlsten; Tillie L Hackett; Chun Y Seow; Peter D Paré
Journal:  BMC Pulm Med       Date:  2017-12-11       Impact factor: 3.317

4.  LAMB3 mediates metastatic tumor behavior in papillary thyroid cancer by regulating c-MET/Akt signals.

Authors:  Seung-Nam Jung; Hyun Sil Lim; Lihua Liu; Jae Won Chang; Young Chang Lim; Ki Sang Rha; Bon Seok Koo
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

5.  Overexpression of α3, β3 and γ2 chains of laminin-332 is associated with poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Jun Chen; Hao Zhang; Jiansheng Luo; Xiaokang Wu; Xueming Li; Xinyi Zhao; Dongkai Zhou; Shian Yu
Journal:  Oncol Lett       Date:  2018-05-09       Impact factor: 2.967

6.  Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinoma.

Authors:  Chengkun Yang; Zhengqian Liu; Xianmin Zeng; Qiongyuan Wu; Xiwen Liao; Xiangkun Wang; Chuangye Han; Tingdong Yu; Guangzhi Zhu; Wei Qin; Tao Peng
Journal:  Aging (Albany NY)       Date:  2019-06-10       Impact factor: 5.682

7.  Upregulation of LAMB1 via ERK/c-Jun Axis Promotes Gastric Cancer Growth and Motility.

Authors:  Hana Lee; Won-Jin Kim; Hyeon-Gu Kang; Jun-Ho Jang; Il Ju Choi; Kyung-Hee Chun; Seok-Jun Kim
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

8.  Integrative analyses identify osteopontin, LAMB3 and ITGB1 as critical pro-metastatic genes for lung cancer.

Authors:  Xiao-Min Wang; Jing Li; Ming-Xia Yan; Lei Liu; De-Shui Jia; Qin Geng; He-Chun Lin; Xiang-Huo He; Jin-Jun Li; Ming Yao
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

9.  Overexpression of β3 Chains of Laminin-332 is Associated With Clinicopathologic Features and Decreased Survival in Patients With Pancreatic Adenocarcinoma.

Authors:  Jun Chen; Weilin Wang; Jianfeng Wei; Dongkai Zhou; Xinyi Zhao; Wei Song; Qiang Sun; Pengfei Huang; Shusen Zheng
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-08

10.  Identification of Therapeutic and Prognostic Biomarkers of Lamin C (LAMC) Family Members in Head and Neck Squamous Cell Carcinoma.

Authors:  Pan Jiang; Shengteng He; Yanli Li; Zheng Xu
Journal:  Med Sci Monit       Date:  2020-08-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.